Clinical Trial Update: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating paclitaxel, cisplatin, and topotecan with or without filgrastim in newly diagnosed stage III or stage IV epithelial ovarian cancer. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Epithelial Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Filgrastim (filgrastim)
• PACLITAXEL (PACLITAXEL)
• Topotecan (topotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma | Phase 1 | Status: COMPLETED